Epidemiology and screening of asymptomatic left ventricular dysfunction

Area of Science:

• Cardiology
• Medical Diagnostics
• Public Health

Background:

• Traditional heart failure prevalence estimates rely on clinical signs and symptoms, yielding figures around 2% for individuals up to 75 years old.
• Recent research incorporates objective evaluations, including echocardiography, to assess systolic and diastolic cardiac function.

Purpose of the Study:

• To compare traditional symptom-based prevalence estimates with those derived from objective cardiac function assessments.
• To highlight the significant number of asymptomatic individuals with ventricular dysfunction.
• To explore the utility of plasma brain natriuretic peptide measurements for early diagnosis.

Main Methods:

• Review of traditional heart failure prevalence data based on signs and symptoms.
• Analysis of newer prevalence data incorporating echocardiographic evaluation of systolic and diastolic function.
• Consideration of plasma brain natriuretic peptide as a potential early diagnostic biomarker.

Main Results:

• Objective evaluations suggest higher heart failure prevalence: 4-5% with depressed systolic function and approximately 5% with moderate to severe diastolic dysfunction.
• A significant proportion, over half, of individuals with ventricular dysfunction are asymptomatic.
• Plasma brain natriuretic peptide is being investigated for its role in early detection.

Conclusions:

• Objective cardiac assessments reveal a greater prevalence of ventricular dysfunction than previously estimated by symptom-based methods.
• The high prevalence of asymptomatic dysfunction underscores the need for advanced diagnostic strategies.
• Simple biomarker tests like plasma brain natriuretic peptide may prove valuable for early identification of ventricular dysfunction.